New monoclonal antibody could be a game-changer in treating rare liver disease by reducing inflammation and fibrosis, says new study

A new monoclonal antibody called nebokitug offers fresh hope to patients who have primary sclerosing cholangitis (PSC), ...

Insider Decision: Roger E Susi Offloads $483K Worth Of iRadimed Stock

Roger E Susi, CEO at iRadimed (NASDAQ: IRMD ), disclosed an insider sell on December 22, according to a recent SEC filing. What Happened: According to a Form 4 filing with the U.S. Securities and ...
PharmiWeb

FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma

Lunsumio VELO reduces administration time from 2-4 hours to approximately one minute –– Availability of Lunsumio VELO allows ...